Showing results (31-40 of 613) with videos related to
Sort By:
Pageof 62
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2012
Validation of an abbreviated quality of life scale for schizophreniaGagan Fervaha, Gary RemingtonPsychological Assessment|July 3, 2013
Invalid responding in questionnaire-based research: implications for the study of schizotypyGagan Fervaha, Gary RemingtonClinical Schizophrenia & Related Psychoses|July 26, 2017
Valbenazine for Tardive DyskinesiaOliver Freudenreich, Gary RemingtonSchizophrenia Bulletin|July 24, 2010
Antipsychotic dosing: how much but also how often?Gary Remington, Shitij KapurPsychopharmacology|June 6, 2013
A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorderHiroyoshi Takeuchi, Gary RemingtonSchizophrenia Bulletin|July 23, 2008
Negative symptoms in schizophrenia: avolition and Occam's razorGeorge Foussias, Gary RemingtonCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 8, 2010
Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-makingGeorge Foussias, Gary RemingtonEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2013
Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal modelMargaret K Hahn, Araba Chintoh, Gary Remington, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|January 11, 2019
Program implementation and effectiveness of a national workplace physical activity intervention: UPnGO with ParticipACTIONErica Y Lau, Guy FaulknerCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 29, 2006
Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medicationsGuy Faulkner, Tony A CohnPageof 62